Avandamet Alternatives

There are a number of Avandamet alternatives available for those who cannot control their blood sugar levels by taking Avandamet. Other oral diabetes medicines may include biguanides, thiazolidinediones, or sulfonylureas. There are also many different types of insulin and other injectable type 2 diabetes medicines, such as incretin mimetics and amylin analogues. Certain lifestyle changes, including diet and exercise, are also an important part of type 2 diabetes treatment.

In September 2010, the U.S. Food and Drug Administration (FDA) announced that it would be severely restricting the use of rosiglitazone, one of the active ingredients in Avandamet, due to the risk of "cardiovascular events" such as heart attacks and strokes. Only individuals who cannot control their diabetes on other medications (or those who are already taking the medication and doing well) will be able to take Avandamet.
 

Avandamet Alternatives Explained

Avandamet® (rosiglitazone and metformin) is a prescription medication used for the treatment of type 2 diabetes. Due to the risk of serious cardiovascular problems (such as heart attacks or strokes), the use of this medication is severely restricted. As a result, people may be searching for suitable alternatives to Avandamet. Fortunately, there are several alternatives to Avandamet.
 
Some of these Avandamet alternatives include:
 
  • Other oral diabetes medications (see Diabetes Medication
  • Lifestyle changes
  • Insulin and other injectable diabetes medications.
      

Oral Diabetes Medications

Fortunately, there are many other different types of oral
 diabetes drugs available to treat type 2 diabetes, including:
 
  • Combination medications
  • Sulfonylureas
  • Biguanides
  • Meglitinides
  • Thiazolidinediones
  • Alpha glucosidase inhibitors
  • Ergot alkaloids 
  • Dipeptidyl peptidase inhibitors.

 

Avandamet is a combination of thiazolidinedione (rosiglitazone) and biguanide (metformin).
Avandamet Alternatives Article Continues on Next Page >
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD
Other Articles in This eMedTV Presentation